ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N05AH03 | G | Olanzapine - 5mg | 7362 | 221893/08 | OLANZAX 5 | 5mg | 30 | Tablet, mouth dissolving | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 1,316,966 L.L | 23.08 | B | Benta SAL | Lebanon | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N05AH03 | B | Olanzapine - 5mg | 6295 | 219704/09 | ZYPREXA VELOTAB | 5mg | 28 | Tablet, dispersible | Oral | Omnipharma | Lilly SA | Spain | 2,607,054 L.L | 23.08 | B | Lilly SA | Spain | 2/5/2024 | 0 |
N05AH03 | G | Olanzapine - 5mg | 8998 | 150816/1 | APO-OLANZAPINE ODT | 5mg | 30 | Tablet, orally disintegrating | Oral | Promopharm S.A.R.L. | Apotex Inc | Canada | 1,317,234 L.L | 23.08 | B | Apotex Inc | Canada | 2/5/2024 | 0 |
N05AH03 | G | Olanzapine - 5mg | 9516 | 92118/1 | OLIZAX 5 | 5mg | 30 | Tablet, mouth dissolving | Oral | Benta Trading Co s.a.l. | Benta SAL | Lebanon | 1,466,580 L.L | 23.08 | B | 2/5/2024 | 0 | ||
N05AH03 | G | Olanzapine - 5mg | 7394 | 96679/12 | PRANZA | 5mg | 30 | Tablet, orodispersible | Oral | Abela Frères S.A.L. | Hikma Pharmaceuticals | Jordan | 1,773,872 L.L | 23.08 | B | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
N05AH03 | G | Olanzapine - 5mg | 11537 | 56023/1 | VAINCOR | 5mg | 28 | Tablet, coated, scored | Oral | Medis Pharm Drugstore | Les Laboratoires Medis | Tunisia | 806,306 L.L | 23.08 | A2 | Les Laboratoires Medis | Tunisia | 2/5/2024 | 0 |
N05AH03 | G | Olanzapine - 5mg | 9279 | 169315/1 | ZOLAPINE | 5mg | 30 | Tablet, orodispersible | Oral | Pharmaline S.A.L. | Pharmaline SAL | Lebanon | 1,186,165 L.L | 23.08 | B | 2/5/2024 | 0 | ||
N05AH03 | G | Olanzapine - 5mg | 6934 | 97459/12 | ZYRWAN OD | 5mg | 14 | Tablet, orodispersible | Oral | Raymond Georges Abou Adal & Co | Adamed Pharma S.A. Ksawerow, Poland for Arwan Pharmaceutical Industries Lebanon SAL | Lebanon | 831,391 L.L | 23.08 | A2 | 2/5/2024 | 0 |